glp 1 lilly FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic New GLP-1 Pill Foundayo (Orforglipron)
Description
A study of health insurance claims found a 44% reduction in hospitalizations for GLP-1 users
Our preclinical findings highlight its potential therapeutic use for patients
Navigating menopause weight loss can be challenging
No injections
Taking GLP-1s during the first trimester of pregnancy does not appear to increase the risk of major adverse outcomes such as non-live birth, according to a new Harvard Chan School study.
